Last updated: October 29, 2020
Sponsor: Commonwealth Scientific and Industrial Research Organisation, Australia
Overall Status: Active - Recruiting
Phase
2
Condition
N/ATreatment
N/AClinical Study ID
NCT04610983
OBP001
Ages 21-50 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy men
- Age: 21-50 years old
- BMI 18-27.5 kg/m2
- Consume less than 2 meals of fatty fish/week
- Not consume fish oil supplements over the past 3 months
- Identify as Australian European in ethnicity (Australian with European heritage) forAustralian arm of study
- Identify as Chinese Singaporean in ethnicity (Singaporean with Chinese heritage) forSingaporean arm of study
Exclusion
Exclusion Criteria:
- History of chronic disease - cancer, type 2 diabetes, cardiovascular disease, liverdisease or any condition that may, in the opinion of the principle investigator,influence the study outcomes (Self reported, no clinical testing will be performed)
- History of gastrointestinal disease, pancreatic insufficiency, conditions resulting infat malabsorption - chronic pancreatitis, cystic fibrosis, coeliac disease, Crohnsdisease, gastric bypass surgery, small bowel resection, abnormal thyroid function (Self reported, no clinical testing will be performed)
- Bleeding disorders, currently taking anticoagulants or has received anticoagulantswithin 28 days of Day 1 of the trial, with the exception of low dose aspirin up to150mg daily (Self reported)
- Any medical procedures deemed by the principal investigator to affect study outcomes
- Known food allergies, hypersensitivity, dietary avoidance or intolerance to the studyfoods
- Taking medications/supplements known to influence lipid metabolism and gastricemptying
- On any weight-loss program
- History of smoking during the 6 months prior to the study (Self reported)
- Persons considered by the investigator to be unwilling, unlikely or unable tocomprehend or comply with the study protocol
- History of drug abuse or alcoholism (Self reported)
- Participation in another research study within 30 days preceding the start of thisstudy
Study Design
Total Participants: 24
Study Start date:
November 16, 2020
Estimated Completion Date:
February 28, 2021
Study Description
Connect with a study center
CSIRO, Health and Biosecurity
Adelaide, South Australia 5000
AustraliaActive - Recruiting
A*STAR
Singapore, 117599
SingaporeSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.